Moreover, no difference was observed in the distribution of diabetes mellitus between tacrolimus and cyclosporine users (Table 1), although previous studies have found that patients receiving tacrolimus had a higher incidence of de novo insulin-requiring diabetes mellitus (Webster et al., 2005a; Haddad et al., 2006). Here, INS is linked to diabetes mellitus.